Table 3.
Plasma anti-FeLV antibodies in cats at the termination of the experiment: a weak positive antibody band was represented by (+) and a strong band by +
| Group | Vaccine |
Cat | Virus isolated from |
Antibody |
|||||
|---|---|---|---|---|---|---|---|---|---|
| Virus | Adjuvant | Plasma | Marrow | VNAb | gp70 | p15E | p27 | ||
| A | FeLV | IL-12 + IL-18 | 1 | − | + | 16 | − | + | + |
| 2 | − | + | 64 | + | + | + | |||
| 3 | − | − | 64 | (+) | + | (+) | |||
| 4 | − | − | 256 | + | + | (+) | |||
| 5 | − | − | 16 | − | + | (+) | |||
| 6 | − | − | 16 | − | (+) | − | |||
| B | FeLV | IL-12 | 8 | + | + | 0 | − | − | + |
| 9 | − | − | 64 | + | (+) | − | |||
| 10 | + | + | 0 | − | (+) | (+) | |||
| 11 | + | + | 16 | + | + | (+) | |||
| 12 | − | − | 1024 | + | + | (+) | |||
| C | FeLV | IL-18 | 13 | − | − | 256 | + | + | (+) |
| 14 | − | − | 0 | + | + | − | |||
| 15 | − | − | 16 | (+) | (+) | − | |||
| 16 | − | − | 16 | + | (+) | − | |||
| 17 | − | − | 4 | (+) | + | − | |||
| 18 | − | + | 256 | + | + | + | |||
| D | FeLV | None | 19 | + | + | 0 | + | + | + |
| 20 | − | + | 0 | + | (+) | − | |||
| 21 | − | − | 64 | (+) | + | (+) | |||
| 22 | + | + | 0 | − | − | − | |||
| 23 | + | + | 0 | − | − | (+) | |||
| 24 | + | + | 0 | + | + | − | |||
| E | None | IL-12 + IL-18 | 25 | − | + | 256 | + | + | − |
| 26 | + | + | 0 | + | + | (+) | |||
| 27 | − | + | 64 | (+) | + | − | |||
| 28 | + | + | 0 | − | (+) | + | |||
| 29 | + | + | 0 | + | + | + | |||
| 30 | − | − | 0 | + | + | − | |||
| F | None | None | 31 | + | + | 0 | − | − | (+) |
| 32 | − | + | 1024 | + | + | (+) | |||
| 33 | + | + | 0 | + | − | + | |||
| 34 | + | + | 0 | (+) | + | − | |||
| 35 | + | + | 0 | + | + | + | |||
| 36 | − | + | 16 | + | + | (+) | |||